StockData
Radiopharm Theranostics Ltd logo

Radiopharm Theranostics Ltd (RADX) stock

RADXNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as RDPTF
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Sep 30, 2026Score 6/30
$0.69+0.01 (+2.10%)

Close on Nov 18, 2026Market cap $8.09MP/E –Yield –

Radiopharm Theranostics net income

Net income is the profit left for shareholders after every expense, interest and tax.

No net income figures for Radiopharm Theranostics

Radiopharm Theranostics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Radiopharm Theranostics figures

See a number that looks wrong?